Introduction
The use of online interventions for diabetes care is increasing, alongside a political drive towards e-health initiatives (1), despite limited robust evidence relating to clinical outcomes. E-health is a term coined in the late 1990s to encompass convergence of the internet and health care.
The definition is constantly changing but generally covers user interaction with health data through online systems, cross transfer of data (often between institutions or systems) and user to user communication. Traditional users of e-health are health institution staff, but a new wave of e-health initiatives directed at patients brings exciting possibilities (2).
More cost-effective diabetes management is needed, and technology could be key to care delivery and diabetes prevention. Around 8-9% of the global population has diabetes (3) . Health expenditure for diabetes is increasing dramatically. The total health care costs of a person with diabetes in the USA are twice to three times those for people without the condition (4). In the UK, annual spending on diabetes is expected to reach 17% of the entire NHS budget over the next 20 years (5).
Around 40% of the world population is now internet-connected (6) rising to around 84% in higher economic countries, like the UK (2015) (7) .
Mobile phone and tablet use in the UK has increased from 30% in 2013 to 41% in 2014 (7) associated with increased use of apps, remote monitors, fitness devices and environmental sensors (8, 9) . Healthcare system data quantity is also increasing exponentially, although it often remains in silos and its true potential thus never realised. Good data linkage and timely data availability to front line health staff has the potential to transform care delivery (10) (11) (12) . This vision is highlighted in key political reports (13, 14) making data and technology use in diabetes care a key priority. As informatics systems mature in their ability to connect and transform data, their outputs can become increasingly personalised, driving individualised support, advice and real-time decision making.
This will become more apparent with the advent of the "Internet of Things" (15) opening up further linkages to community devices containing sensors and electronics. This forthcoming tsunami of health related data will move into the realm of genuine 'Big Data', requiring 'Data Science' approaches to extract meaning and useful knowledge (16) .
Artificial intelligence techniques will increasingly be used to predict future events from data patterns, allowing early intervention. This level of informatics maturity could have particular benefits for selfmanagement and complications prevention in long-term conditions (17,18).
Aims
In this article, we discuss i) the evidence for e-interventions in the management of diabetes, and (23)).
Evaluation of Internet Tools
Systematic reviews and meta-analyses of e-interventions in the management of diabetes have demonstrated acceptability and improvement in glycaemic control of participants, although the effects are often modest and variable across studies (24) (25) (26) (27) . These reviews contain heterogeneous interventions, which are often outdated by the time of publication, but suggest that goal setting, personalised coaching, interactive feedback, mobile use and online peer support may predict success when applied to management of type 2 diabetes mellitus.
Evaluation of different categories of e-interventions is discussed below:
m-health 8 Self management interventions delivered through mobile technology tend to be more successful than browser based systems (24, 26) .
Systematic reviews suggest m-health interventions can improve HbA1c
(28), although impact is variable (29) . A systematic review (2014) of available diabetes applications, of which 656 were reviewed in full, showed apps to be feasible with moderate to good usability in patients over age 50 (30) . Apps can support self-management of patients with diabetes mellitus type 1 or 2 (31,32) and aid glycaemic improvements (33) .
Social Media
Gilbert et al found that online communities are a valued resource by Type I diabetes patients for peer support (34) . Story telling, sharing of experiences and tips for self management are common themes. Whilst healthcare staff are often concerned about sharing of personal data online, patients are generally happy to share with peers for mutual benefit (32) . Little research has been conducted evaluating impact on glycaemic outcomes (21, 31, 35) .
Telemedicine/Virtual Clinics
Freeman et al (36) found low-cost online video services such as "Skype", to be feasible for providing online virtual clinics (37), allowing more flexible communication, whilst maintaining the patient-provider relationship, a strong predictor of medical adherence (36 (39) . A meta-analysis revealed that using selfmonitoring blood glucose data, stored in and/or shared through a personal data assistant, logbook, the internet and other technologiesworked well alongside consistent feedback from a healthcare professional. This resulted in enhanced glycemic improvements and reduced hospitalisations (40) .
Electronic Personal Health Record (ePHR)
A Nuffield Trust report (41) (46)).
Personalised Tailored Education
Individual patient data drives tailored links to specific educational resources to aid personal self-management. Examples include foot care information tailored to a persons foot risk, drug administration guidance dependent on personal prescribing records, and links to specific sections of a retinopathy educational video based on individual retinal screening results. In addition patients can view tailored lifestyle advice dependent on dynamic changes in anthropometric and biochemical readings.
MyDiabetesMyWay. Use, Effectiveness and Future Developments
Usage 
 "I don't have to make appointments to see GP or nurse which is good as I work and don't like taking time off work"
Key findings from a recent evaluation survey of 1,098 MDMW users who had logged in at least once prior to January 2015 (27.5% response rate) include; 89.6% felt it helped them make better use of their consultation, 88.2% felt it helped them manage their diabetes better and 90.3% and 89.3% respectively felt it improved their knowledge and motivation. 
Clinical Improvements and Cost Effectiveness
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MDMW Current and Future Developments
The MyDiabetesMyWay platform evolution has been driven by patient preference and the wider published evidence base. Further planned functionality includes:
 an associated m-health app  enhanced automatic data collection and integration from environmental and activity sensors.
 algorithm development and machine learning to enable timely tailored "push" decision support to mobile devices and timely warnings of acute deterioration to patients and clinicians.
These later developments would align with a high level of health informatics maturity with potential for personalised, real-time medical support systems. There is huge potential to deliver online selfmanagement to empower and increase knowledge and self-management capabilities of patients.. Widespread, low-cost web access is lessening the economic, geographic and demographic barriers for use. Technology approaches however will only work if patients are willing, motivated and able to use them.
Technology must be intuitive, and include automaticity where possible, and must ease rather than add to daily care activities. Further understanding of user requirements and motivation is required. Unless technology is accessible across the range of socioeconomic, ethnic, disability and age spectrums then it will continue to be the pursuit of limited numbers of motivated patients, and will fail to greatly impact on population health outcomes.
